Health Archive » December, 2022

Health - December, 2022

308 articles

• Software Not Covered In Ransomware Attack, Ohio Justices Say
• The Most-Read Legal Industry Law360 Guest Articles Of 2022
• Judge Awards La. Doctors' Cos. $70M In Arbitration 'Mess'
• ITC Says Apple Watch Infringes Patents But Holds Off On Ban
• 11th Circ. Says Fla. Vaccine Requirement Appeal Isn't Moot
• Wash. Jury Awards $82M In Latest School PCB Trial
• The Top Patent Damages Awards Of 2022
• Insurers Slam Scouts Plan; FTX To Start Clawback Actions
• Facebook Users Denied Injunction In 'Troubling' Privacy Suit
• Insurer Can't Shake Default Coverage Ruling, 9th Circ. Told
• French Medical Co. Wants €4.2M Award Over Failed Expansion
• The Biggest Moves In Cannabis Law And Policy From 2022
• Migrant Kids' Attys Settle For $577K Fee In Shelter Suit
• Mich. High Court Won't Fast-Track AG's Eli Lilly Insulin Probe
• Key Developments From State Attorneys General In 2022
• DC Circ. Urged To Overturn Endo-Impax Opioid Deal Win
• DC City Council Eases Restrictions On Medical Pot Program
• 6th Circ. Blocks Ky. Abortion Clinic 'Buffer Zone,' For Now
• The Biggest Georgia Rulings Of 2022
• Athenahealth Whistleblowers Lose Atty Fee Bids In 1st Circ.
• 2022 Law And Policy Highlights In Digital Health Care
• 6th Circ. Tosses 5 Cases Over COVID-19 Insurance Claims
• Health Care Co. Hit With OT Suit Over Work During Breaks
• What 3 Legal Industry Trends From 2022 Mean For Next Year
• UK Litigation Roundup: Here's What You Missed In London
• Chancery Tosses AmerisourceBergen Opioid Suit
• Amgen Fights HHS' Drug Discount Claims At DC Court
• Bowling Green Gets College Virus Refund Class Decertified
• UnitedHealth Faces ERISA Suit Alleging Overcharging Scheme
• Native American Land Transfer Bills Sent To Biden's Desk
• 2nd Circ. Preserves Insurer's Win In 2 Construction Cases
• Judge Trims Boston Scientific Investor's Stock Suit
• Next Compliance Steps For Health Cos. Using Tracking Tech
• Accused 'Pill Mill' Doc Asks 3rd Circ. To Toss Guilty Plea
• Learning From This Year's Legal Industry Discrimination Suits
• Wash. AG Says Kroger, Others Helped Fuel Opioid Epidemic
• Top Government Contracts Cases Of 2022
• Abrupt Layoffs Push Insurance Broker Into WARN Act Fight
• Biggest Developments In Antitrust Conduct Cases In 2022
• NYC Theater Co. Prods 2nd Circ. To Revive Vax Injury Suit
• Walmart, CVS, Albertsons To Pay $189M In NM Opioid Deals
• Texas Court Says Title X Violates Parents' Rights
• BioTelemetry, CardioNet To Pay $44.8M To Settle FCA Case
• 2nd Circ. Tosses Hospital's $5.5M Medicaid Dispute With HHS
• WTO Dispute Roundup: New Delays Heading Into 2023
• Mich. Hospital Network Says Software Co. Can't Sue In NY
• Good Samaritan Driver Can't Attack Mask Rule, 7th Circ. Says
• Ga. Man Gets 20 Years For Ponzi And COVID Fraud Schemes
• Texas Man Resentenced To 12 Years For Tricare Fraud
• 2nd Circ. Says FCA Claims Against Fresenius Already Public
• J&J Expert Says Talc Claims Process To Move Swiftly
• The Future Of Legal Ops: AI Has Important Role To Play
• State Regulators Want 11th Circ. To Tweak $2.67B BCBS Deal
• Top Trends And Challenges For Health Care Financing In 2022
• Blue Cross Unit, Lab Come To Terms On COVID-19 Test Claims
• 4 Proactive Strategies For 'Rocket Docket' Discovery In SDNY
• Teva, Glenmark Get May 2024 Price-Fixing Criminal Trial
• Plaintiffs Seek OK On $255M Juul MDL Economic Settlement
• Monsanto Wins 11th Circ. Redo Of Ga. Doctor's Roundup Case
• Biotech CEOs Lied About HIV Drug, Feds Say
• How DC Became A Consumer Protection Pioneer
• 11th Amendment Doesn't Block Hawaii Hemp Suit, Co. Says
• Florida's Medical Marijuana Industry: 2022 In Review
• Philips Says It Didn't Mislead CPAP Cleaner Co.'s Customers
• 2022 Data Privacy Suits Tested New Liability Theories
• The 7 Biggest Massachusetts Top Court Rulings Of 2022
• ITC Commission Staff Says Suspend Apple Watch Import Ban
• Jury Concerns Spur Mistrial In $158M Health Care Fraud Trial
• Jazz Pharma Asks Fed. Circ. To Reverse Orange Book Delisting
• To Beat Overbilling Allegations, Cigna Says Everybody Does It
• Teen Wins Blue Cross Bias Suit Challenging Trans Care Ban
• Ohio Panel Rejects Eye Specialist's Virus Coverage Appeal
• Planned Parenthood Slams 'Deficient' Texas Privilege Claims
• Catching Up With Delaware's Chancery Court
• Express Scripts Says Sanction Bid A Tactic Of A Failed Case
• Bayer Asks Chancery To Toss Merck's Talc Liability Suit
• Medical Malpractice Settlements Shouldn't Require NDAs
• Novartis And Grifols Say Abbott Can't Tank HIV Test Patent
• 6th Circ. Revives Ohio State Sex Abuse Victims' Suits
• Nurse Seeks Court's Approval On Forced Labor, OT Wage Deal
• Hospital Manager Looks For OK Of $2.9M Gabon Award
• 9 Considerations For Landlords Renting To Cannabis Cos.
• 5 Drug Pricing Issues To Watch In 2023
• NC Justices Say Treatment Notes Not Privileged Documents
• NY Ruling Is A Ch. 15 Reminder For Practitioners Outside US
• Walmart Tells High Court To Skip Pharmacist's Race Bias Case
• Calif. Atty Cops To Illegal Sale Of $1.3M Health Co. Shares
• Doctor-Assisted Suicide Not Protected, Mass. Top Court Rules
• Judge OKs $75M Ch. 11 Loan From Clovis Secured Lender
• Juul's Massive E-Cig Marketing Deal Won't Derail Altria Trial
• USTR Seeks More Data As WTO Delays COVID-19 IP Vote
• Ind. Chiropractor Who Fractured Patient's Spine Beats Suit
• DOJ Says Alaska Unfairly Institutionalizes Native Children
• How EU's New Pharma Incentives May Affect US Cos.
• Fired Ohio Hospital CEO Sues Again Over Ouster
• Opana End-Payors Get Final OK Of $15M Impax Deal
• Janssen Thwarting Docs Order In Kickback Suit, Court Told
• 2nd Circ. Scrutinizes Trustee In $39.2M Tilton Award Appeal
• What Really Doomed Kidney Test Patents In Fed. Circ. Ruling
• Leading Conservative Atty Retires After Decades At Jones Day
• Calif. AG Approves Hospital Merger
• Health Hires: Barnes & Thornburg, BillionToOne
• UK Litigation Roundup: Here's What You Missed In London
• $2.6M Sex Harassment Win Tossed Over Hearsay Concerns
• Increasing Law Firm Polarization Will Degrade Rule Of Law
• Lawyer, Doctor Convicted Of Fueling $31M Trip-And-Fall Scam
• FDA Warns CBD Cos. About COVID Claims
• Judge Breathes 6 Months Of Life Into AstraZeneca Patent
• Fla. Whistleblower Suit Nets $3M Over Medicare Kickbacks
• 3rd Circ. Won't Revive Health Plans' Suits Over Opioid Drug
• Therapy Patients Tell 4th Circ. Insurer Owes Fraud Coverage
• Med Mal Atty Gets In Shouting Match With Pa. Wiretap Judge
• Monsanto Inks $698M Deal To End Oregon Pollution Suit
• Navigating Uncertainties In Section 340B Drug Pricing
• Clovis Oncology Ch. 11 Loan Process Down To The Wire
• Chancery Says AmerisourceBergen Suit Not Time-Barred
• PerkinElmer Says Lab Must Face Claim Over COVID Gear
• Cook Co. Prosecutor Fired For Arrest Conduct, Not Disability
• Breast Implant Maker Gets Injury Suit Tossed
• Texas Appeals Court Axes Anti-SLAPP Fee Award In IP Fight
• 2022 Hurdles Failed To Deter DOJ Antitrust Enforcement Goals
• Best Practices For Cannabis Cos. Managing A Product Recall
• Coca-Cola Distributor Fired Medical Pot Patient, Suit Alleges
• Gov't Can't Prove ACA Fines Are Taxes, Retailer Tells DC Circ.
• Alleged Insider Trader Sues For Fees In Del. Bioverativ Suit
• Teamsters Local, Coke Distributor Close To Benefits Suit Deal
• HHS Pans Pfizer's 'Far-Fetched' Kickback Views At High Court
• Biggest Illinois Decisions Of 2022
• Health Net Hit With $14.4M Verdict Over Surgery Delay
• Mich. Panel Hears Latest Challenge On Auto Policy Overhaul
• Judge Won't Stop Bid To Block Tape In Med Mal Suit
• Claims Court Trims Tricare Outpatient Underpayment Dispute
• Texas Justices Say No Remote Jurors In J&J Pelvic Mesh Trial
• Masimo Launches Counterattack In Apple Watch IP Fights
• Split 6th Circ. Won't Rehear Ohio State Sex Abuse Case
• Fed. Circ. Pauses 'Orange Book' Delisting For Jazz Drug
• Georgia Agencies Sued For Failure To Cover Trans Benefits
• Navigating The Unique Challenges Of An OIG Investigation
• What To Expect From Colo. Therapeutic Psychedelics Law
• Feds Decry 'Fraud Like No Other' As $31M Scam Trial Closes
• NY Investment Firm Closes Fund Above Initial Target At $530M
• Why States Need Clear Standards For Cannabis Testing Labs
• SPAC Investors Sue In Del. After Talkspace Value Plunge
• Steel Co. Veto'd Job Offer After Positive Pot Test, Suit Says
• LabSolutions CEO Guilty In $187M Telemed Billing Scheme
• Feds Fight Georgia Judge's Finding of 'Vague' Hacking Case
• Two Lenders Vie For $75M Clovis Oncology Ch. 11 DIP Loan
• How To Deal With Difficult Clients, Practically And Ethically
• DeSantis Petitions Fla. Justices For COVID-19 Vax Grand Jury
• Illumina Tells FTC Commissioners Grail Deal Will Save Lives
• Teva, Apotex Win Ax Of Patents In Sleep Drug Suit
• Medical Device Co. Strikes $14.5M Deal To Settle FCA Claims
• Glove Co. Wants $68M Labor Probe Concealment Suit Ended
• UPMC Atty Says She Left Probe Of Surgeon's Tape To Feds
• $2.7B BCBS Deal 'Sold Out' Some Claimants, 11th Circ. Told
• HHS Bulletin Raises HIPAA Risks For Online Tracking Vendors
• Atty Pleads Not Guilty To Attempted Medical Biz Takeover
• Ex-NBA Players Can't Ditch Health Plan Fraud Charges
• Ravgen Fetal DNA Testing Patent Survives PTAB Review
• Munger Tolles & Olson Promoting 3 To Partner In 2023
• 6th Circ. Rejects Challenge To Opioid MDL Fee Order
• Butzel Opens Grand Rapids Office With Litigation Firm Merger
• Phillips & Cohen Adds Former Assistant US Attorney
• Lab Director Gets 5 Months For Duping FDA Before Outbreak
• Ky. Ruling Shows Need For Consistent Insurer Claim Replies
• Medly Health Gets OK To Tap $4M In Ch. 11 Financing
• Vape Co. Can't Undo FDA Denial Of Flavored E-Cig Fluids
• Juul To Pay Pa. $38.8M To Settle Youth Marketing Claims
• Ohio Court Revives Allergic Reaction Medical Malpractice Suit
• Blue Cross Aims To Duck Loss In Transgender-Care Bias Case
• Deliberations Start In $187M Genetic Testing Scheme
• Biz Owner Can't Nix 50 Cent's Suit On Penile Enhancement Ad
• Collective Can Stay In OT Suit Against Health Care Co.
• Feds Cut Deal With Pharmacy In Prescription Kickback Suit
• Biotech Co. Gets Investor Suit Over Failed COVID Test Tossed
• UK Medical Staffing Co. Ruled To Owe $202K In VAT
• Walgreens And CVS Finalize $10.7B Opioid Fallout Deal
• Catching Up With Delaware's Chancery Court
• Fla. Animal Doctor Gets 10 Months For Doping Racehorses
• Texas Nursing Home Can't Escape Brain Injury Death Suit
• Federal Courts Should Adopt Supreme Court's Amicus Stance
• The 2022 Law360 Pulse Leaderboard
• Top Firms Make Growth A Priority For 2023
• Detroit Says Updated Cannabis Ordinance Is Constitutional
• Medly Health Files For Ch. 11 With Plans To Sell 22 Stores
• Clovis Oncology Hits Ch. 11 With $754.5M Debt And Sale Plans
• Supreme Court Won't Hear EMS Worker's Overtime Case
• Medical Device Co. Blames Judge For Sinking Patent Case
• Biden Urged To Block Fed Aid For Anti-Abortion Enforcement
• Equipment Co. Seeks Coverage For Surgical Gown Recall
• Centene Stockholder Sues In Alleged Medicaid Fraud Scheme
• ITC Delays Final Ruling On Apple Watch Import Ban
• Key Witness In $31M Scam Trial Forgets Details During Cross
• Sober Home Brings Fight With NJ Town To 3rd Circ.
• 8th Circ. Mostly Backs Religious Groups' Trans Policy Block
• Philips Wants Latest CPAP Foam MDL Complaint Tossed
• SmileDirectClub Can't Use Plan Denials To Show Defamation
• Novavax Brass Sued In Del. For Touting Failed COVID Vaccine
• Judge Tosses Medicaid Fraud Class Action Against NJ Firm
• BakerHostetler Seeks To Move Fraud Claims To District Court
• NY Panel's COVID Nursing Home Case Order Spurs Questions
• Drugmaker's Knowledge Of Suits Bars Coverage, Court Told
• 1st Circ. Revives Puerto Rico Urologists' Antitrust Case
• UK Litigation Roundup: Here's What You Missed In London
• Apple Files Emergency ITC Motion To Block Smartwatch Ban
• DEA Should Face Discrimination Trial, Ex-Agent Says
• DOJ's Only Wage-Fixing Trial Conviction Results In Probation
• Texas Abortion Provider Gets Bounty-Hunter Suit Tossed
• Geico Seeks $2.4M From Health Centers For False Claims
• MAO Assignee Says MSP Act Preempts State Law, Contracts
• Calif. Health System Not Covered For FCA Probe, Insurer Says
• 6th Circ. Takes On Kentucky Abortion Clinic's 'Buffer Zone'
• Lab Exec Seeks Probation For FDA Fraud Tied To Outbreak
• DOL Board Backs Vitamin Shoppe's Foreign Manager Cert. Bid
• Texas AG Says Mallinckrodt Trust Can't Be Used For Atty Pay
• Bid Protest Spotlight: Best-Value Trade-Offs, Solicitations
• FDA Graphic Cigarette Warnings Go Up In Smoke
• Fla. Rep Behind Controversial Bill Indicted For COVID Fraud
• Merck Sheds Nearly 1,200 Shingles Vaccine Suits
• Insurer Slams Discrimination Claim In Spat With Medical Co.
• Ga. Judge Won't Toss 'Complex' $400M Kickbacks Case
• Ex-Florida Pain Doctor Gets 3½ Years For Insys Kickbacks
• Novartis Can't Beat Suit Over Eye Injection Treatment
• Amazon's PillPack Can't Avoid TCPA Suit
• Health Co. Inks $4M Deal To End Suit Over Hemp Co. Buyout
• Critics Say Kids Online Safety Bill Violates 1st Amendment
• 6th Circ. Mulls Rejecting 2-Step FLSA Collective Procedure​​​​​​​
• Short-Seller Says Health Care REIT Welltower Masks Losses
• Ex-Theranos Exec Balwani Gets Nearly 13 Years For Fraud
• Gov't Recommends High Court Review Intent In FCA Cases
• Apple Beats Patent Claims At PTAB After Loss At ITC
• Justices Seem Disinclined Toward Any Major FCA Upheaval
• 5th Circ. Revives Some Medtronic Pacemaker Claims
• Data Broker Kochava Slams FTC's Privacy Suit As 'Illogical'
• Squire Patton Boggs Lands Senior DOJ Fraud Litigator
• Va. Care Co. Must Pay $1.5M For Shorting Workers On OT
• Arnold & Porter Punished For Opioid Lapses, Averts Contempt
• Fla. Court Axes Zantac MDL Claims, Citing Lack Of Experts
• Juul Cuts Deal To End MDL On Eve Of Bellwether Trial
• Balwani May Get More Prison Time Than Holmes, Experts Say
• Ex-Asst. Atlanta City Atty Stole $7M In COVID Aid, Feds Say
• Justices Skeptical About Limits On Gov't FCA Dismissal Right
• 9th Circ. Backs CVS' Win Over $121M Drug Overcharge Claim
• Juul Founders Say NY's Illict Marketing Claims Must Fall
• 3rd Circ. Backs Pitt's Win In Croatian Ex-Instructor's Bias Suit
• FTC Staff Warn Against Changing Juul-Altria Standard
• Dems Press Patent Office On Pharma 'Abuse' Of System
• NC Health Plan's Trans Care Ban Violates ACA, Judge Says
• Magellan Investor's Attys Seek $1.1M Fee In Centene Deal Suit
• Gov't Says Gilead Can't Shake HIV Drug Patent Suit
• NJ Opioid Treatment Center Pays $3M To End Kickback Claims
• USTR Calls For More Time On IP Waiver Expansion Decision
• Former Grizzlies Guard Avoids Jail In NBA Health Plan Case
• Ohio Atty Accused Of Hiding Past In New Career Bid
• Elizabeth Holmes Asks To Stay Out Of Prison During Appeal
• Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
• 9th Circ. Skeptical Of Hospital Challenge To COVID 'Hero Pay'
• Fed. Circ. Chief Judge Chews Out 'Aggressive' Quinn Atty
• Actelion Hit With RICO Suit Over Blood Pressure Drugs
• Del. Court Won't Pause 'Orange Book' Delisting
• Mistrial Declared When DOJ Springs Emails After Jury Seated
• Federal Circuit Revives Doctor's Retaliation Suit
• Dem Lawmakers Propose Huge Investment In Indian Country
• Essilor To Pay $23.8M To End Calif. Insurance Fraud Probe
• Facing Potential ITC Ban, Apple Files IP Suit Over Health Tech
• Mont. Tribe Can Intervene In COVID Rule Case, Judge Says
• US-EU Talks Bring Barrage Of New Tech, Trade Initiatives
• SEIU Wants Nursing Homes To Arbitrate Dues Dispute
• Catching Up With Delaware's Chancery Court
• EU Wants Illumina To Unwind $8B Grail Deal 'Swiftly'
• 3rd Circ. 'Loss' Definition Is A Win For White Collar Defendants
• Ariz. Tribal Hospital, IHS Want Mediation In Funding Dispute
• CSX Must Face Rail Worker's Cancer Suit, Appeals Court Says
• Justices Won't Hear Appeal Of Long-Running Swisher Case
• Aetna, Patients Reach Deal To End Surgery Coverage Suit
• 3 Pricing Trends In Law Firm Use Of Litigation Funding
• The 2022 Law360 Pulse Prestige Leaders
• In Law Firm Race For Revenue, Top Dogs Stand Alone
• DHS Cyber Review Board To Probe Lapsus$ Extortion Crew
• Elizabeth Holmes Appeals Conviction, Sentence To 9th Circ.
• States Lean On La. Title 42 Order To Enter Asylum-Seekers' Suit
• Doctor Repped By RFK Jr. Targets COVID Misinformation Law
• CVS, Walgreens Take Aim At $650M Opioid Verdict
• Ohio Hospital's Vax Policy Violated Religious Rights, Suit Says
• CORRECTED: Cannabis REIT Wants Out Of Risky Investment Claims
• Bias Protections At Stake In High Court LGBTQ Wedding Case
• Biden Signs Marijuana Research Bill Into Law
• CDC Wants Cancellation Of $100M 9/11 Health Program Deal
• Compliance Considerations For Virtual Ketamine Clinics
• Interest Rates Doom Lender, Crypto Winter Persists
• Alcon Gets More J&J Unit Eye Surgery IP Axed At PTAB
• UK Litigation Roundup: Here's What You Missed In London
• Safeguarding Attorneys' Greatest Asset: Our Mental Health
• How 6th Circ. Flint Ruling Adds To 5th Amendment Case Law
• LA Man Convicted Of Attempted $1.9M COVID Fraud
• Theranos Exec Balwani Wants Probation As Feds Seek 15 Yrs.
• Top Opioid Target Kroger Inks $85M Deal, With $25M For Attys
• 11th Circ. Backs Ex-Doctor's Conviction In Prescription Case
• Masimo Clarifies Some Proxy Notice Rules Hit In Del. Suit
• Judge Orders Preemption Briefing In Organ Transplant Suit
• Biotech Co. Accuses Citadel Securities, Others Of Spoofing
• Unlicensed Doctor Negates Med Center's Coverage, Court Told
• BCBS Calls New Bid To Remand Pot Coverage Suit 'Baseless'
• Walgreens Provides Deficient COBRA Notices, Suit Says
• Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver
• Pharma Co. Slams Bid To Delay 'Orange Book' Delisting
• Trans W.Va. Medicaid Participants Urge 4th Circ. To Affirm Win
• Lab Exec Gets 1 Year For FDA Fraud Tied To Deadly Outbreak